Class and example |
Mechanism of action |
Side effects |
Biguanide e.g. metformin |
· ↓Hepatic glucose production (by glycogenolysis, gluconeogenesis) · ↑Insulin sensitivity |
· Diarrhoea · Renal impairment: ↑risk if dehydrated, iodine contrast, other nephrotoxins. · Rare lactic acidosis (inhibit complex 1 of electron transport chain) |
Sulfonylurea e.g. gliclazide |
· Inhibit K+-ATP channel -> depolarisation -> activate VDCC -> ↑ICF Ca2+ -> exocytosis of insulin vesicles ↑insulin release · Requires functioning pancreas |
· Risk hypoglycaemia peri-op · Long-term “burnout”, β-cell failure, insulin dependence · |
Apical SGLT2 inhibitor e.g. dapagliflozin |
· ↓Glucose reabsorption -> glycosuria · Limit plasma glucose to 10mM · Weight loss |
· UTI · Osmotic diuresis · Occult DKA-like state |
a-glucosidase inhibitor e.g. acarbose |
· ↓Glucose reabsorption · Weight loss |
· Osmotic diarrhoea, abdominal pain |
DPP4 inhibitor e.g. sitagliptin |
· ↓Breakdown of incretins GLP-1 and GIP · Requires functioning pancreas |
· Minimal · Nausea · Cold-like symptoms · Photosensitivity |
Thiazolidenedione PPARγ agonists e.g. rosiglitazone |
· ↓Insulin resistance |
· Weight gain, oedema, hepatitis |
Feedback welcome at ketaminenightmares@gmail.com